Jefferies Financial Group’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-5,886
Closed -$574K – 1431
2026
Q2
$574K Sell
5,886
-196,524
-97% -$17.2M ﹤0.01% 1211
2026
Q1
$17M Buy
+202,410
New +$11.7M 0.12% 146
2024
Q2
– Sell
-7,600
Closed -$228K – 1518
2024
Q1
$228K Sell
7,600
-5,600
-42% -$122K ﹤0.01% 1304
2023
Q4
$137K Hold
13,200
– – ﹤0.01% 1515
2023
Q3
$180K Buy
+13,200
New +$166K ﹤0.01% 1364

Other funds holding DNTH

Jefferies Financial Group's DNTH Position: Q3 2026 in Review

Jefferies Financial Group sold out of Dianthus Therapeutics (DNTH) in Q3 2026, closing a stake of 5,886 shares — an estimated $574K sold.

Jefferies Financial Group first reported a position in DNTH in Q3 2023 and held it in 5 quarters. The position peaked at $17M in Q1 2026. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

  • Jefferies Financial Group reported no remaining Dianthus Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 5,886 Dianthus Therapeutics shares in Q3 2026, an estimated $574K.
  • Jefferies Financial Group first reported a position in Dianthus Therapeutics in Q3 2023 and held it in 5 quarters.
  • Jefferies Financial Group's Dianthus Therapeutics position peaked at $17M in Q1 2026.
  • 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.